e/acc biomed picks a hard target: metabolism
obesity, insulin, gut‑brain community steers, docs open, IP liquid
@BioProtocol builds the stack
BioXP, veBIO, Launchpad, audited IP tokens → funding that iterates
@FatDAO_ lines cohorts
GLP‑1 off‑ramp, CGM readouts, microbiome probiotics → low‑cost replicable interventions, buyback pressure when data clears
clinical gates are slow, rigor matters
outcomes or noise, choose your lane
vote with replies:
GLP‑1 off‑ramp
microbiome trials
IP splits
tag a builder who should join, one pick only